School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Emergent BioSolutions Inc. EBS

Healthcare · Drug Manufacturers - Specialty & Generic

$6.98last close 2026-10-12 · market cap $357.89M · delayed data

Trailing returns

1M+12.04%
3M-13.29%
6M-12.31%
1Y-23.04%
5Y-86.34%

Basis: Adjusted daily closes.

What it does

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments.

Open EBS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies